Market Closed -
OTC Markets
09:48:12 2024-03-08 am EST
5-day change
1st Jan Change
0.0001
USD
+9,900.00%
-.--%
-.--%
Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014
May 28, 2014 at 03:19 am EDT
Urologix, Inc. reported earnings results for the third quarter and nine months ended March 31, 2014. The company has reported that net loss for the third quarter ended March 31, 2014 was $1.66 million, or $0.08 loss per share, compared to a net loss of $1 million, or $0.05 loss per share, for the same quarter ended March 31, 2013. Sales for the third quarter ended March 31, 2014 were $3.36 million, compared to $4.08 million for the same quarter ended March 31, 2013.
Net loss for the nine months ended March 31, 2014 was $4.08 million, or $0.19 loss per share, compared to a net loss of $3.04 million, or $0.15 loss per share, for the same period ended March 31, 2013. Sales for the nine months ended March 31, 2014 were $10.94 million, compared to $12.40 million for the same period ended March 31, 2013.
A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.
16-02-01
CI
Urologix Conducting A Strategic Review
15-07-09
CI
Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015
15-05-12
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015
15-05-12
CI
Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015
15-03-23
CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014
15-02-05
CI
Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015
15-02-05
Urologix, Inc. Announces Revenue Guidance for Second Quarter Ended on December 31, 2014
15-01-12
CI
Transcript : Urologix, Inc., Q1 2015 Earnings Call, Nov 04, 2014
14-11-04
Urologix, Inc. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2014; Provides Cash Flow Guidance for the Fiscal 2015
14-11-04
CI
Transcript : Urologix, Inc., Q4 2014 Earnings Call, Aug 19, 2014
14-08-19
Urologix, Inc. Announces Executive Changes
14-08-19
CI
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Reports Impairment of Goodwill for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2015
14-08-19
CI
Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014
14-05-28
CI
Transcript : Urologix, Inc., Q3 2014 Earnings Call, May 06, 2014
14-05-06
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014
14-05-06
CI
Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014
14-04-10
CI
Transcript : Urologix, Inc., Q2 2014 Earnings Call, Feb 04, 2014
14-02-04
Urologix Secures Extension of Credit Facility
14-02-04
CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2013
14-02-04
CI
Urologix, Inc. Reports Revenue Results for the Second Quarter Ended December 31, 2013; Withdraws Previously Issued Fiscal Year 2014 Revenue Guidance
14-01-08
CI
Transcript : Urologix, Inc., Q1 2014 Earnings Call, Oct 29, 2013
13-10-29
Urologix, Inc. Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2013; Reaffirms Revenue Guidance for Fiscal 2014
13-10-29
CI
Transcript : Urologix, Inc., Q4 2013 Earnings Call, Aug 20, 2013
13-08-20
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2013; Provides Revenue Guidance for the Fiscal Year 2014; Reports Impairment Charges for the Fourth Quarter Ended June 30, 2013
13-08-20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1